Traws Pharma Inc Cash Flow-to-Debt Ratio
Traws Pharma Inc cash flow-to-debt ratio. Traws Pharma Inc (TRAW) has a Cash Flow-to-Debt Ratio of -0.77x as of June 2026, meaning its operating cash flow of $-7.50 Million could theoretically repay -1% of its total liabilities ($9.78 Million) in one year. Check Traws Pharma Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Traws Pharma Inc (2011–2025)
Cash flow-to-debt ratio of Traws Pharma Inc from 2011 to 2025. Historical debt coverage capacity for Traws Pharma Inc across 15 annual periods. Check Traws Pharma Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Traws Pharma Inc Cash Flow-to-Debt Ratio by Year (2011–2025)
Traws Pharma Inc cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Traws Pharma Inc. For the full cash flow conversion analysis, see TRAW cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.62x | $-18.18 Million | $11.25 Million | ▼ -207.2% |
| 2024 | -0.53x | $-29.79 Million | $56.59 Million | ▲ +64.7% |
| 2023 | -1.49x | $-17.93 Million | $12.01 Million | ▼ -1.4% |
| 2022 | -1.47x | $-16.29 Million | $11.06 Million | ▲ +29.3% |
| 2021 | -2.08x | $-19.49 Million | $9.36 Million | ▼ -24.6% |
| 2020 | -1.67x | $-23.07 Million | $13.81 Million | ▲ +3.0% |
| 2019 | -1.72x | $-20.83 Million | $12.10 Million | ▲ +4.9% |
| 2018 | -1.81x | $-22.70 Million | $12.54 Million | ▼ -20.4% |
| 2017 | -1.50x | $-23.82 Million | $15.84 Million | ▼ -72.2% |
| 2016 | -0.87x | $-15.81 Million | $18.11 Million | ▲ +64.8% |
| 2015 | -2.48x | $-31.31 Million | $12.61 Million | ▼ -2.2% |
| 2014 | -2.43x | $-57.65 Million | $23.71 Million | ▲ +4.0% |
| 2013 | -2.53x | $-61.38 Million | $24.25 Million | ▼ -37632.1% |
| 2012 | 0.01x | $1.63 Million | $242.16 Million | ▲ +106.8% |
| 2011 | -0.10x | $-14.17 Million | $142.88 Million | — |